Methods and compositions for treating fish diseases
AssigneeHalosource, Inc.
InventorsMichael A. Bridges, Christine M. Palczewski, James R. Scott, Jeremy Suess, Everett J. Nichols
Life of this patent
Estimating the term…
Abstract
Therapeutic and prophylactic treatments of aquatic species and aquatic diseases through the controlled introduction of a heterocyclic N-halamine into an aquatic habitat.
Claims14
A composition for treating an aquatic habitat, comprising 100% by weight, in combination, of an effective amount of 1-chloro-2,2,5,5-tetramethyl-4-imidazolidinone and magnesium sulfate, wherein the composition is bound by compression and dissolves to produce a slow rise of the imidazolidinone concentration to achieve a concentration of not more than about 20 ppm over a time period of about 6 hours in the aquatic habitat to treat a disease of an aquatic species.
A method for treating a disease in an aquatic habitat, comprising dosing a composition comprising 100% by weight, in combination, of an effective amount of 1-chloro-2,2,5,5-tetramethyl-4-imidazolidinone and magnesium sulfate into the aquatic habitat, wherein the composition is bound by compression and dissolves to achieve a concentration of the imidazolidinone of not more than about 20 ppm over a time period of about 6 hours in the aquatic habitat to treat a disease of an aquatic species.
A method for treating an aquatic species suffering from a water-borne disease, comprising dosing a composition comprising 100% by weight, in combination, of an effective amount of 1-chloro-2,2,5,5-tetramethyl-4-imidazolidinone and magnesium sulfate into an aquatic habitat of the aquatic species, wherein composition is bound by compression and dissolves to achieve a concentration of less than about 20 ppm of the imidazolidinone over a time period of about 6 hours.
A device to treat an aquatic habitat, comprising:
- a receptacle to hold a composition comprising 100% by weight, in combination of an effective amount of 1-chloro-2,2,5,5-tetramethyl-4-imidazolidinone and magnesium sulfate;
- the imidazolidinone is within said receptacle;
- and
- means for controlling the release of said imidazolidinone from said device to achieve a concentration of not more than about 20 ppm of the imidazolidinone over a time period of about 6 hours.
Dependencies are inferred from the claim text.